Skip to main content
. 2023 Jan 29;15(3):682. doi: 10.3390/nu15030682
BPH Benign prostatic hyperplasia
AOS Alginate oligosaccharide
AR Androgen receptor
SRD5A2 5α-reductase type 2
PSA Prostate-specific antigen
LUTS Lower urinary tract symptoms
DHT Dihydrotestosterone
PCNA Proliferation cell nuclear antigen
iNOS Inducible nitric oxide synthase
COX-2 Cyclooxygenase-2
Gapdh Glyceraldehyde-3-phosphate dehydrogenase
TNF-α Tumor necrosis factor-α
FGF-2 Fibroblast growth factor-2